Last SFr.85.75 CHF
Change Today -1.50 / -1.72%
Volume 474.8K
As of 11:43 AM 04/24/14 All times are local (Market data is delayed by at least 15 minutes).

actelion ltd-reg (ATLN) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/28/14 - SFr.93.45
52 Week Low
06/24/13 - SFr.52.80
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ACTELION LTD-REG (ATLN)

Related News

No related news articles were found.

actelion ltd-reg (ATLN) Related Businessweek News

No Related Businessweek News Found

actelion ltd-reg (ATLN) Details

Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for diseases with unmet medical needs. Its products include Tracleer, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertension (PAH), a chronic and life-threatening disorder that severely compromises the functions of the lungs and heart; Opsumit, an orally available endothelin receptor antagonist; and Valchlor, a chemotherapeutic agent for the treatment of mycosis fungoides, a common type of cutaneous T-cell lymphoma. The company also provides Veletri, a formulation of epoprostenol for the treatment of PAH; Ventavis, an inhaled formulation of iloprost for the treatment of PAH; and Zavesca, an oral treatment for patients with mild to moderate type 1 Gaucher disease for whom enzyme replacement therapy is unsuitable. Actelion Ltd markets its products in Switzerland, the United States, Japan, China, Russia, and Mexico. The company was founded in 1997 and is headquartered in Allschwil, Switzerland.

2,396 Employees
Last Reported Date: 02/7/14
Founded in 1997

actelion ltd-reg (ATLN) Top Compensated Officers

Founder, Chief Executive Officer, Member of M...
Total Annual Compensation: SFr.2.6M
Compensation as of Fiscal Year 2013.

actelion ltd-reg (ATLN) Key Developments

Actelion Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2014

Actelion Ltd. reported earnings results for the first quarter ended March 31, 2014. For the period, the company reported core operating income of CHF 189 million, core net income of CHF 170 million or CHF 1.46 per fully diluted share against core operating income of CHF 169 million, core net income of CHF 141 million or CHF 1.23 per fully diluted share a year ago. US-GAAP operating income was CHF 153 million compared to CHF 124 million a year ago. Revenues were CHF 469 million compared to CHF 433 million a year ago. Operating cash flow was CHF 96 million compared to CHF 95 million a year ago. The company reported net income of CHF 127.51 million, or CHF 1.09 per diluted share compared to CHF 97.95 million, or CHF 0.85 per diluted share, for the same quarter ended March 31, 2013. Operating income was CHF152.81 million, compared to CHF124 million for the same quarter ended March 31, 2013. Income before income tax expense was CHF142.32 million, compared to CHF114.96 million for the same quarter ended March 31, 2013.

Actelion Ltd. Proposes Dividend; Armin Kessler to Step Down as Board of Director

The Annual General Meeting of Actelion Ltd. will be held on May 8, 2014. At the meeting the shareholders will propose a 20% increase in the dividend payment, to CHF 1.20 per share. After 10 years of service on Actelion's Board of Directors, Armin Kessler will be stepping down at the General Meeting will be held on May 08, 2014.

Actelion Ltd. Proposes Changes to Articles of Association

Actelion Ltd. proposed changes to Articles of Association to ensure compliance with the Federal Council's Ordinance in relation to the Minder initiative, to its Annual General Meeting of shareholders will take place on May 8, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATLN:VX SFr.85.75 CHF -1.50

ATLN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Analog Devices Inc $54.21 USD +0.92
BioMarin Pharmaceutical Inc $60.69 USD +1.50
Marvell Technology Group Ltd $15.97 USD +0.1601
Meda AB kr116.50 SEK +2.80
Regency Energy Partners LP $27.42 USD +0.13
View Industry Companies

Industry Analysis


Industry Average

Valuation ATLN Industry Range
Price/Earnings 21.0x
Price/Sales 5.3x
Price/Book 5.7x
Price/Cash Flow 19.7x
TEV/Sales 5.1x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTELION LTD-REG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at